Over 80% of patients with pancreatic ductal adenocarcinoma (PDAC) are diagnosed at a late stage and are locally advanced or with concurrent metastases. The aggressive phenotype and relative chemo- and radiotherapeutic resistance of PDAC is thought to be mediated largely by its prominent stroma. which is supported by an extracellular matrix (ECM). Therefore. https://parisnaturalfoodes.shop/product-category/colour-bath-violet/